A Study of a Decision Tool for People Considering Breast Reconstruction Surgery

Breast Reconstruction Decision Aid (RECONJOINT)

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT07335354

Enrollment

131

Registered

2026-01-13

Start date

2026-01-05

Completion date

2029-01-05

Last updated

2026-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Brief summary

The purpose of this study is to find out whether it is practical (feasible) to do a larger study looking at the effectiveness of the Breast Reconstruction Decision Aid Tool (RECONJOINT) for breast reconstruction surgery.

Interventions

OTHERRECONJOINT

RECONJOINT is a Breast Reconstruction Decision Aid

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

OTHER

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

Participant Inclusion Criteria Focus Group Participants * A diagnosed genetic predisposition to breast cancer or a diagnosis of ductal carcinoma in situ or any invasive cancer confirmed through review of the medical record * ≥18 years old * Considering post-mastectomy breast reconstruction RCT Participants (Patients) * A diagnosed genetic predisposition to breast cancer or a diagnosis of ductal carcinoma in situ or any invasive cancer confirmed through review of the medical record * ≥18 years old * Considering post-mastectomy breast reconstruction * Have an appointment scheduled for consultation with a plastic surgery provider RCT Participants (Physicians) * Provides breast reconstruction care ≥ 50% of the time. This is defined as over half of the surgeon's cases in the preceding calendar year being related to breast reconstruction surgery. Participant

Exclusion criteria

Focus Group Participants * Not considering post-mastectomy breast reconstruction * Non-English proficiency RCT Participants (Patients) * Not considering postmastectomy breast reconstruction * Recurrent or metastatic breast cancer * Male sex * Non-English proficiency RCT Participants (Physicians) * Does not provide breast reconstruction care at least 50% of the time * Non-English proficiency

Design outcomes

Primary

Measure	Time frame	Description
Feasibility determined by participant accrual	<60 days after initial reconstructive surgery consult and before pt's breast reconstruction surgery	Determine the feasibility of a hybrid effectiveness-implementation study that investigates the effectiveness and implementation potential of a decision aid to improve shared decision-making in breast reconstruction.

Countries

United States

Contacts

CONTACTEvan Matros, MD

matrose@mskcc.org646-608-8044

CONTACTCarrie Stern, MD

sternc2@mskcc.org646-608-8048

PRINCIPAL_INVESTIGATOREvan Matros, MD

Memorial Sloan Kettering Cancer Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 10, 2026